Rafael Holdings invests $5M in Cyclo Therapeutics for 4M shares and warrant

Rafael Holdings, Inc.

Rafael Holdings to purchase 4M shares of Cyclo Therapeutics common stock plus warrant for additional 4M shares at $1.25 per share; total investment $5M.
Warrant exercisable at $1.25/share for 7 years from issuance.
Closing subject to Cyclo stockholder approval per Nasdaq Listing Rule 5635.
Rafael Holdings gets board designee (additional to CEO William Conkling) on Cyclo's board.
Registration rights agreement amended to require filing for resale of shares and warrant shares upon request.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.